The study by Koh et al1 makes a meaningful contribution by demonstrating that catheter ablation for atrial fibrillation (AF) delivers consistent quality-of-life (QoL) and mood improvements across a wide socioeconomic spectrum—evidence that directly strengthens the case for equitable procedural access. We offer 3 methodological observations for constructive discussion.
First, participants were drawn exclusively from randomized controlled trials, settings systematically enriched for adherent, motivated patients.2 In routine practice, individuals with lower socioeconomic status (SES) disproportionately encounter structural barriers, including transportation limitations, employment constraints, and reduced health literacy, which trial populations rarely reflect. A null SES-outcome relationship within this filtered cohort may therefore underestimate disparities present across the broader AF community.
Second, women constituted only 22% of participants. Women with AF consistently present with greater symptom burden and receive differential treatment compared with men.3 Whether SES modifies postablation QoL recovery differently by sex cannot be addressed in a predominantly male sample.
Third, the primary QoL score merged Atrial Fibrillation Effect on Quality-of-Life questionnaire (N = 131) and Atrial Fibrillation Severity Scale (N = 23) via min-max normalization. Both instruments were independently developed and validated using distinct item structures and patient populations.4,5 Rescaling to a shared numerical range does not achieve psychometric equivalence; it disregards each tool’s measurement model and is sensitive to boundary values. The 6-fold sample imbalance further marginalizes Atrial Fibrillation Severity Scale contributions within the pooled composite. Null conclusions derived from this hybrid end point require instrument-specific replication before informing access policy.
We commend the authors for initiating this important conversation and look forward to future studies incorporating community-based AF cohorts, balanced sex enrollment, and instrument-specific outcome analyses.
Acknowledgments
Funding Sources
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Disclosures
The authors have no conflicts of interest to disclose.
Authorship
All authors attest they meet the current ICMJE criteria for authorship.
References
- 1.Koh Y., Chen L., Lu L., et al. Socioeconomic status does not influence quality of life and mood outcomes after catheter ablation for atrial fibrillation. Heart Rhythm O2. 2026;7:46–52. doi: 10.1016/j.hroo.2025.10.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Rothwell P.M. External validity of randomised controlled trials: “to whom do the results of this trial apply?”. Lancet. 2005;365:82–93. doi: 10.1016/S0140-6736(04)17670-8. [DOI] [PubMed] [Google Scholar]
- 3.Dagres N., Nieuwlaat R., Vardas P.E., et al. Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe. J Am Coll Cardiol. 2007;49:572–577. doi: 10.1016/j.jacc.2006.10.047. [DOI] [PubMed] [Google Scholar]
- 4.Spertus J., Dorian P., Bubien R., et al. Development and validation of the Atrial Fibrillation Effect on QualiTy-of-Life (AFEQT) questionnaire in patients with atrial fibrillation. Circ Arrhythm Electrophysiol. 2011;4:15–25. doi: 10.1161/CIRCEP.110.958033. [DOI] [PubMed] [Google Scholar]
- 5.Dorian P., Jung W., Newman D., et al. The impairment of health-related quality of life in patients with intermittent atrial fibrillation. J Am Coll Cardiol. 2000;36:1303–1309. doi: 10.1016/s0735-1097(00)00886-x. [DOI] [PubMed] [Google Scholar]